MedTrace Logo

Coherence Imaging of the Cervical Epithelium

NCT02903394 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2018-11-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to develop a multiplexed low coherence interferometry (mLCI) endoscopic probe for mapping the epithelial types of the cervix. This vaginal mLCI probe will obtain optical measurements from the cervix. These measurements can be used to create a map of the surface cells that distinguishes ectocervical epithelia, endocervical epithelia, and the squamocolumnar junction (t-zone), which is the region where cervical dysplasia is most likely to occur.

Conditions

  • Cervical Epithelia

Interventions

DEVICE

mLCI Device

imaging of cervical epithelium using mLCI device

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Jacobi Medical Center

    collaborator OTHER

  • Duke University

    lead OTHER

Principal Investigators

  • Adam Wax, Ph.D. · professor

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
36 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-27
Primary Completion
2017-10-24
Completion
2017-10-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02903394 on ClinicalTrials.gov